Clinical Trial Update: Study of LM11A-31-BHS in Mild-moderate AD Patients [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial of LM11A-31-BHS in patients with mild to moderate Alzheimer's disease has completed recruitment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• LM11A-31-BHS

Snippet

Sponsor: PharmatrophiX Inc. | Conditions: Mild to Moderate Alzheimer's Disease | Phase 1, Phase 2 | Status: COMPLETED